- Home
- FSI vs ACHL Comparison
FSI vs ACHL Comparison
Compare FSI & ACHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSI
- ACHL
- Stock Information
- Founded
- FSI 1991
- ACHL 2016
- Country
- FSI Canada
- ACHL United Kingdom
- Employees
- FSI N/A
- ACHL N/A
- Industry
- FSI Recreational Games/Products/Toys
- ACHL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FSI Consumer Discretionary
- ACHL Health Care
- Exchange
- FSI Nasdaq
- ACHL Nasdaq
- Market Cap
- FSI 47.3M
- ACHL 46.8M
- IPO Year
- FSI 1999
- ACHL 2021
- Fundamental
- Price
- FSI $5.99
- ACHL $1.15
- Analyst Decision
- FSI
- ACHL Buy
- Analyst Count
- FSI 0
- ACHL 2
- Target Price
- FSI N/A
- ACHL $4.00
- AVG Volume (30 Days)
- FSI 1.0M
- ACHL 266.6K
- Earning Date
- FSI 11-14-2024
- ACHL 11-14-2024
- Dividend Yield
- FSI 1.63%
- ACHL N/A
- EPS Growth
- FSI 11.03
- ACHL N/A
- EPS
- FSI 0.33
- ACHL N/A
- Revenue
- FSI $38,493,925.00
- ACHL N/A
- Revenue This Year
- FSI $0.73
- ACHL N/A
- Revenue Next Year
- FSI $34.59
- ACHL N/A
- P/E Ratio
- FSI $18.64
- ACHL N/A
- Revenue Growth
- FSI N/A
- ACHL N/A
- 52 Week Low
- FSI $1.65
- ACHL $0.63
- 52 Week High
- FSI $6.44
- ACHL $1.76
- Technical
- Relative Strength Index (RSI)
- FSI 79.70
- ACHL 57.79
- Support Level
- FSI $3.57
- ACHL $1.12
- Resistance Level
- FSI $6.44
- ACHL $1.18
- Average True Range (ATR)
- FSI 0.44
- ACHL 0.05
- MACD
- FSI 0.27
- ACHL -0.00
- Stochastic Oscillator
- FSI 84.81
- ACHL 44.44
About FSI Flexible Solutions International Inc. (CDA)
Flexible Solutions International Inc develops, manufactures, and markets specialty chemicals that slow the evaporation of water. Its business is organized into two segments Energy and Water Conservation Products, and Biodegradable Polymers. It offers a liquid swimming pool blanket under the WATERSAVR brand, which saves energy and water by inhibiting evaporation from the pool surface, a chemical product called HEATSAVR, for use in swimming pools and spas to slow the water evaporation. The firm also manufactures and markets water-soluble chemicals utilizing thermal polyaspartate biopolymers. It generates most of its revenues from the export of its products to international markets.
About ACHL Achilles Therapeutics plc
Achilles Therapeutics PLC is a biopharmaceutical company. It is developing AI-powered precision T-cell therapies targeting clonal neoantigens to treat solid tumors. The company has two ongoing trials, the CHIRON trial in patients with non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.